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Introduction
Infravesical obstruction (IVO) is a polyetiological and 
pathological condition caused by a number of urological dis-
eases, which lead to an impaired urinary elimination from 
the bladder because of an obstruction in the bladder neck or 
urethral region.
According to statistical data, infravesical obstruction oc-
curs in 50% of men aged 60 years and 90% of those who 
reached the age 85. Among men with infravesical urody-
namic disorders, obstructive uropathy occurs in 20-35% of 
cases, and hydronephrosis, as a complication, – in 3.8% of 
cases [1]. In 23.9% of cases, infravesical obstruction in older 
men is conditioned by the development of prostate sclerosis, 
whereas benign prostate hyperplasia (BPH) associated with 
sclerotic changes is the commonest one [2]. Obstructive 
uropathy, caused by prostate disorder occurs in 5% of new 
cases of hemodialysis, in population aged over 65 years [3].
Any kind of micturition disorders may significantly re-
duce quality of life, develop psychological problems, which 
can affect family and employment relationships, and lead 
to social isolation. Besides the life-threatening conditions 
patients may experience, micturition disorders can lead to 
serious physical and moral sufferings, caused by deep psy-
chological trauma, sexual conflict, the onset of neurosis and 
neurasthenia. From the psychological perspective, IVO is 
often associated with depressive disorders and is the most 
difficult pathology to diagnose. The long-lasting evolution, 
persistent dysuria and frequent recurrences may sometimes 
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arise a feeling of hopelessness among patients regarding 
their treatment.
Infravesical obstruction is caused by urological diseases, 
which lead to the impairment of urinary evacuation, mic-
turition difficulties, retention of urine and other types of 
dysuria. Infravesical obstruction is a characteristic symptom 
related to the following diseases like (fig. 1): adenoma of the 
prostate or benign prostatic hyperplasia, prostate cancer, 
bladder cancer (particularly located in the bladder neck), 
prostate and bladder neck sclerosis, urethral stricture and 
obliteration etc. [1,4].  The urodynamic resconstructure of 
urinary tract and the remodeling of regional renal and pelvic 
blood flow occur in infravesical obstruction [5, 6].
Subvesical obstruction, which causes the impairment of 
urinary evacuation, leads to urinary infection of both lower 
and upper tracts, and may commonly develop into cysti-
tis and pyelonephritis. The obstacle in the urinary passage 
causes disturbance of micturition, which may eventually 
become worse viz. stranguria; pollakiuria; urinary incon-
tinence (paradoxical ischuria) and the presence of residual 
urine, which is a polyetiological and pathological process, 
characterized by symptoms of lower urinary tract,which  still 
remains a difficult problem for fundamental and practical 
medicine [7, 8].
Recently, there have been made a number of scientific 
researches in order to determine the causes of infravesical 
obstruction and optimize the best-corrected medical and 
surgical methods of treatment [9, 10].
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The latest scientific clinical trials and technical progress 
have changed considerably the traditional urological treat-
ment approach for many urinary diseases (fig. 1), which may 
result in infravesical obstruction i.e. benign prostatic hyper-
plasia, strictures and extended obliterations of the urethra, 
bladder neck and prostate sclerosis etc. [11].
Infravesical obstruction is most commonly met in old 
age and, in most cases, is caused by the development of a 
hyperplastic process in the prostate [12,13,14]. Benign pros-
tatic hyperplasia is one of the most widespread polyetiologi-
cal diseases in men of elderly and senile age, which occurs 
due to the proliferation of the transitional zone of the pros-
tate, and paraurethral glands and lead to lower urinary tract 
obstruction [2, 15, 16, 17].
In this regard, according to the epidemiologic data, HBP 
was detected in 40% of men aged between 50 and 60 years, 
in 50% of men over 60 and in 90%–100% – after 80 years 
[2, 9, 18, 19]. It is considered that most men, over the age of 
50, show certain symptoms caused by BPH [19], whereas the 
high life expectancy rates of aging men lead to an increased 
number of patients suffering from this disease [15]. Lately, 
some authors [20] mention the growth of BPH morbidity 
rates in population amongst most of countries.
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Fig 1. Urological disorders leading to infravesical obstruction.
Infravesical obstruction caused by benign prostatic hyperplasia
The widespread BPH in men identifies the acute prob-
lem of timely diagnosis and well-reasoned treatment in the 
pathogenesis of this disease. It is extremely important, while 
choosing a reliable method of treatment for patients with 
BPH, to perform an accurate diagnosis of the disease and 
consider the shape of the prostate hyperplasia, degree of in-
fravesical obstruction, prostate volume, as well [8, 21].
According to F. Schroder and I. Altwein [158], J.D. Mc 
Connell et al. [22], the clinical manifestations of BPH are 
detected in 34% of men aged 40-50 years, 67% of men aged 
51-60 years, 77% of cases aged 61-70 years and 83% of men 
older than 70 years. Similar data were presented by other au-
thors [23, 24].
In terms of clinical studies, the disease shows various 
symptoms related to the impairment of the urine passage 
through the lower urinary tract [25]. The causes of mictu-
rition disorder are infravesical urethral obstruction and 
underactive detrusor. The obstruction is caused by the en-
largement of prostate with the gradual narrowing of the ure-
thral lumen (mechanical component) and the hypertonus of 
smooth muscle fibres of the prostate and posterior urethra 
(dynamic component) (Fig. 2). On the basis of secondary 
changes of the detrusor with obstructed genesis, the stres- 
sors (direct influence of catecholamines) and ischemic (va-
sospasm) lesions of the smooth muscle elements of the blad-
der are of great importance. In these cases the bladder sup-
ports a large influence of catecholamines and, as a result of 
this process, disorders in bioenergetics and detrusor func-
tion occur  [26, 27].
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Fig. 2.  The pathogenesis of impaired micturition in patients 
with BPH (A. Sivkov and co., 2009) [86].
Both theoretical and practical knowledge of the patho-
genetic mechanisms present great importance in the devel-
opment of obstructive uropathies. The research results of 
multilateral mechanisms of the pathogenesis of infravescal 
obstruction facilitate the detection of obstructive uropathies 
at the early stages, which enables the optimization of treat-
ment methods in patients from the perspective of modern 
concepts, regarding the pathogenesis of this disorder, and 
allows the monitoring and timely performing of necessary 
changes in the selected treatment schemes.
Nowadays, the problem of benign prostatic hyperplasia 
treatment remains a current issue [17, 28, 29, 30]. Over the 
past 20 years, there has been an opportunity to treat patients 
at early stages of the disease using pathogenetically substan-
tiated drug theraphies [8]. The successful obtained results, 
in the study of the pathogenesis of prostatic hyperplasia and 
the use of medicinal treatment with pathogenetic oriented 
mechanism, made the drug therapy possible and truly ef-
fective for certain categories of patients, affected by this di-
sease. However, drug therapy does not relieve completely the 
patient’s condition with  prostatic hyperplasia, since phar-
macotherapeutical methods show short-acting effectiveness 
and are applied to a limited number of patients with BPH 
(with Ist stage), therefore about 30-40% of men suffering 
from BPH, at present, remain subjects to surgical therapy 
[31, 32].
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Unfavorable criteria characteristic for progression of 
prostatic hyperplasia are as follows:
– Prostate-specific antigen (PSA) is increased over 4 ng / 
ml in blood serum;
– Prostatic hyperplasia volume over 45 cm3 (the possibi-
lity of a prostate edema in acute inflammatory process 
should be considered);
– IPSS scoring more than 7;
– Low urinary maximum flow rate (less than 10 ml/s).
Additionally, the patient’s age and associated diseases 
play a significant role in choosing the treatment techniques, 
especially in surgical treatment.
Modern urology provides many methods of treatment 
of this disease [9,15,33], but the most radical procedures are 
considered the surgical methods only, which include open ad-
enomectomy and transurethral resection of BPH [31,34,35]. 
Modern Urological clinics perform TURP in 98.2% of cases 
and open interventions in 1.7-2.1% of cases [36].
In the treatment of large benign prostatic hyperplasia, 
transvesical adenomectomy has long been considered as 
main surgical method [28]. But despite its high efficiency, 
the rate of postoperative complications shows higher indices 
compared to endoscopic interventions. Thus, the total num-
ber of complications after a transvesical adenomectomy is 
between 12.5% – 23.02%, and according to C. G. Roehrborn 
data [37], this indicator reaches 38.5%. After transurethral 
resection, the postoperative complication rates range from 
14.95% [22] to 18% [28,39]. Complications differ by struc-
ture as well; thus in late postoperative adenomectomy the 
incidence of bladder neck sclerosis ranges from 2.9% to 7.1% 
of cases [39,40], and stricture of the urethra – up to 5.1% 
[41]; while after transurethral resection,  these parameters 
vary between 0.77% and 1.7% [25] and from 2.6% to 7, 14% 
of cases, respectively [28].
Therefore, a major issue of modern surgery today, is the 
choice of surgical methods of treatment for patients with 
late obstructive complications of transvesical adenomecto-
my [42]. Obstructive complications (bladder neck sclerosis 
and posterior urethral stricture), which are detected in 1.5% 
-9.2% of cases [43] may lead to  the sudden worsening of the 
micturition and usually require extra special treatment, a cor-
rection performed by  endoscopic therapy exclusively [38].
Transurethral prostatectomy or transurethral resection 
of the prostate is the second generation of surgical methods 
for the treatment of obstructive uropathies caused by benign 
prostatic hyperplasia 
[44].  In fact, according to data of international meet-
ings (American and European Association of Urology) for 
the treatment of prostatic hyperplasia, as well as different 
authors’ opinions, transurethral resection of the prostate 
(TURP) is considered the “gold standard” treatment of BPH 
[29,33,38].
This method of treatment substituted open adenomecto-
my, and is applied in  70% -95% of patients as an alternative 
method to the surgical treatment procedures of BPH and in-
fravesical obstruction caused by it [33,45,46] and also repre-
sents from 63.7 to 98.3% of all invasive procedures for treat-
ment of prostatic hyperplasia [21,34]. Actually, this  method 
is equally efficient compared to an open surgery and simul-
taneously, it shows a number of advantages like less trauma, 
lower risk of recurrence in patients, fewer complications, re-
duced hospital stays, shorter rehabilitation period, low post-
operative mortality rate, etc. [15,17]. TURP implementation 
has contributed to considerable broadening of indications to 
surgical treatment for patients with BPH and pronounced 
recurrent diseases, who until recently were doomed to a life-
long elimination of urine through cystostomy [33,47,48].
However, it is worth mentioning, that in addition to its 
high efficiency, surgical treatment entails some risks of de-
veloping intra- and postoperative complications, which may 
occur in 8-22% of patients [9,12,49]. Additionally, in case of 
some categories of patients with BPH, open prostatectomy 
(adenomectomy) or TURP are life-threatening or contrain-
dicated procedures, whereas drug therapy is inefficient due 
to the pronounced symptoms of infravesical obstruction 
[38]. Such patients are often bound to live with cystostomy, 
which seriously reduces their quality of life and leads to so-
cial inadequacy of the patient.
Despite its high clinical efficiency, TURP has a number 
of complications, which are detected in 25.67% of operated 
patients [9,17,50]. These include false and true recurrences 
of BPH, intra– and postoperative bleeding, TUR syndrome, 
urinary incontinence, bladder neck sclerosis, urethral stric-
ture, retrograde ejaculation, etc.
Thus, according to A. Martov et al. [18] and N. Sergienko 
et al. [14], patients with BPH, following TURP presented 
early intraoperative and postoperative bleeding in 11.5% of 
patients, acute urethritis – 5.8%, acute epididymitis – 29%, 
acute urinary retention – 5.4%, maintainance of irritative 
symptoms in the late postoperative period – 10.6%, bladder 
neck sclerosis – 4.2%, urethral stricture – 6.9%, incontinence 
of urine – 1.6% of cases.
Complications of transurethral resection are divided 
into early and late intraoperative and postoperative ones 
[9,17,18]. During intraoperative and early postoperative 
periods, the following complications may occur: profuse 
hemorrhage, signs of water intoxication (TURP syndrome), 
urinary tracts injury,  acute urinary retention, infections and 
inflammatory complications; whereas during late postop-
erative period , complications like maintainance of  irritative 
symptoms, urethral stricture, bladder neck sclerosis, incon-
tinence of urine, disease recurrence, retrograde ejaculation 
may commonly occur. Many of these complications require 
repeated surgery [9,25].
Retrospective analysis of TURP complications [51] 
showed that the occurrence of intraoperative and early 
postoperative complications is related to the level of train-
ing of TURP techniques (it has been reduced from 21 to 
4.2%). In this regard, a considerable attention is paid to the 
peculiarities of form and morphological structure of BPH, 
since the inflammatory complications occurred on the al-
ready pre-existing diseases (chronic prostatitis and chronic 
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pyelonephritis). According to the authors, scarce results of 
endoscopic interventions characterized by persistent irrita-
tive symptoms were determined, in most cases by dynamic 
components, simultaneously with detrusor dysfunction. In 
this case, incorrect indications and unjustified surgical treat-
ment play an important role in the development of compli-
cations and require further scientific and practical research.
The highest percentage of all postoperative complications 
refers to infravesical obstruction recurrence. According to 
M. Trapeznikova et al. [52], the recurrent postoperative IVO 
may be early (immediate) and late. In fact, early postopera-
tive IVO recurrence has technical aspects of interventions, 
whereas late postoperative IVO is caused by scarring of the 
urethra and vesico-urethral portion (strictures and oblit-
erations) and the continuous growth of adenomatous tissue 
(true or false recurrence of BPH) [9,25].
The existing scientific studies, regarding the problem of 
postoperative complications of transvesical adenomectomy 
and transurethral resection, as well as the measures used 
to prevent them, do not clarify a number of issues, such as: 
causes of complications in the postoperative period; their 
relation to the morphological structure of the prostate; the 
dependence of the late complications development on the 
early postoperative period development. Until nowadays, 
there is no clear picture of the recurrent causes of infravesi-
cal obstruction after BPH, mechanisms of its development, 
methods of treatment and prophylaxis.
According to A. Martov et al. analysis [17,18,53], the in-
cidence of postoperative complications following the new 
endoscopic interventions of  prostatic hyperplasia showed, 
that the major problem in the early period of standard TURP, 
is still  a relatively high frequency of bleeding complications, 
especially in cases when blood transfusions were required. In 
the later periods of rotoresection and „vaporized“ resection, 
there was a higher incidence of bladder neck sclerosis (10%) 
and urethral stricture after TURP in 6.9% cases. Therefore, 
minimally invasive alternative methods, such as TURP will 
successfully solve the problem of infravesical obstruction, 
whereas a number of complications restrict their use in clini-
cal practice. According to the same group of authors [17], 
new transurethral endoscopic interventions highly reduce 
the number of intraoperative complications.
Despite the continuous improvement of surgical treat-
ment, postoperative complications still remain at a high lev-
el of incidence and do not tend to decrease. There have not 
been sufficiently studied the particularities of clinical pro-
gression of large BPH [54], nor the development of it, as well 
as identification and treatment of infravesical obstruction in 
patients with median lobe hyperplasia of BPH.
Clinical manifestations of BPH are largely dependent 
upon the patterns of nodular hyperplasia growth and vol-
ume, which eventually lead to infravesical obstruction. It is a 
well-known fact that in patients with BPH, hyperplasia may 
occur in the lateral lobes, median lobe or all three lobes of 
the gland simultaneuosly [43].
There has been already established the role of so-called 
median lobe hyperplasia (MLH) of the prostate in the de-
velopment of infravesical obstruction [55]. Some authors 
[56,57] consider the specific feature of median lobe of BPH, 
is inefficiency in treatment of this disease via different drug 
therapies.
Up to now, we have little information on the peculiari-
ties of diagnosis and treatment of patients with BPH median 
lobe hyperplasia [58]. There are known only basic criteria 
that would contribute to an objective assessment of the par-
ticipation degree of the median lobe hyperplasia, concur-
rently with the lateral lobes, in the evolution of infravesical 
obstruction in patients with BPH.
Complex research data on urodynamics (pressure-flow) 
also confirm the presence, characteristics and expressiveness 
of infravesical obstruction. It is also important to determine 
the role of an enlarged median lobe of BPH, which acts as 
a valve in the development of infravesical obstruction, and 
as a risk factor of possible complications following surgical 
interventions, as well as its effect on late treatment outcomes 
in such patients.
Traditionally, TURP treatment was applied to a rela-
tively small prostate volume – up to 80 cm3. But along with 
the improvement of transurethral surgery, this method has 
been used to remove the large prostate gland, as well, about 
100-120 cm3 (the mandatory requirement is sufficient ex-
perience of the surgeon). Larger BPH (over 80 cm3) were 
detected in 10-20% of patients with this pathology. The re-
moval of adenoma of such dimensions is possible through 
various means, including: transvesical and retropubic ade-
nomectomy, transurethral resection, laser enucleation of the 
prostate, transurethral bipolar enucleation (TURBE). There 
have already been developed various techniques of trans-
urethral interventions according to the size of gland hyper-
plasia. Thus, prostate vaporization is applied to a prostate 
gland volume of 30 cm3, TURis BPH in 35-80 cm3 volume, 
TURBE – 90-250 cm3.  According to A. Martov et al. (2014), 
transurethral enucleation in larger BPH (over 100 cm3) is an 
alternative method to open adenomectomy or transurethral 
resection of the prostate (TURP). The method combines the 
minimally invasive TURP and radical pattern of open sur-
gery. No doubt, minimally invasive interventions are more 
preferable compared to open adenomectomy. The removal 
of enucleated nodes can be performed via morcellators, by a 
common resection loop for TURP procedure and by cysto-
tomic access for large bladder gallstones [54,59].Due to the 
obtained results following transurethral electroenucleation 
procedures using morcellators in HBP of various sizes, a 
number of authors were able to conclude [54,59] that trans-
urethral electroenucleation of prostate (TURBE) by morcel-
lation is an effective method to treat large BPH. The high 
speed of morcellator enables to reduce the time of interven-
tion, and the obtained material is completely useful for his-
tological research in terms of ensuring adequate irrigation 
and hemostasis quality.
However, TURP is not applied on a prostate gland vol-
ume of 150 cm3 and larger, because of the high incidence 
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of intraoperative complications (bleeding, TUR syndrome, 
etc.), which will increase in number along with the hyper-
plasia tissue growth following an electroresection [12,19,49].
Moreover, complications after standard transurethral re-
section are more likely to occur i.e. the intraoperative and 
postoperative hemorrhage (in 0.9 to 10% of patients) and 
“ water intoxication” syndrome  (0.1-1% of patients)  have 
led to the onset of minimally invasive alternative technolo-
gies, including endoscopic treatment of patients with HBP 
– methods that show efficiency and are comparable to TURP 
and would decrease the number of complications and fail-
ures [12,25,49].
The list of alternative technologies has expanded consid-
erably in recent years and includes drug therapy, stenting, 
balloon dilatation, hyperthermia and thermotherapy, ultra-
sound and needle ablation, interstitial clotting, transurethral 
microwave therapy(TUMT) , as well as administration of 
ethyl alcohol (ethanol) and Botox, etc. Although, these tech-
niques decrease the number of complications, they still can-
not be compared to transurethral resection in terms of ef-
ficiency, both clinically and economically [60]. These meth-
ods have not been widely used either due to their inefficiency 
or because of the unfavorable complications [15,60].
The current, third period in the treatment of BPH is 
characterized by the rapid development of new endoscopic 
technological methods, which do compete with TURP in 
BPH treatment, being considered as the basic method of 
treatment during the last decades.
Bipolar transurethral resection of the prostate [30], Holmi-
um laser (HoLEP) ablation (enucleation) [54,61,62,63,64,65] 
and transurethral vaporization of the prostate (TUVRP) 
show new means of BPH treatment [61,63,66].
Each of the methods has its own advantages and disad-
vantages. Availability of instruments, surgical skills and the 
indications for one or another method may largely deter-
mine the successful outcome. TURP of the prostate can be 
monopolar or bipolar; using the thin or thick loop [29,67]. 
Bipolar TUR of the prostate is associated with less bleeding 
and low risk of developing dilutional hyponatremia.
In the early 90s, the development of endoscopic elec-
trosurgical technologies of prostate has led to the onset of 
a new method: Transurethral electrovaporization. Electro-
vaporization combines the advantages of the standard trans-
urethral resection (immediate tissue removal, optical control 
of intervention, clinical and economical effectiveness) and 
a considerable decrease of intra– and postoperative bleed-
ing ,as well as prevention “of water intoxication” of the body 
[42,49]. Transurethral vaporization, which uses thick cunei-
form loop, causes vaporization and resection of the prostatic 
tissue, which is followed by a less hemorrhage and character-
ized by a shorter duration of intervention [ 42,68].
However, the practice shows that electrovaporization 
of prostate has its own disadvantages, too. Thus, e.g. “roller 
vaporization,” which is the easiest technique to learn from 
the entire spectrum of electrosurgical methodologies used 
in treatment of BPH (simple technical management,  good 
endoscopic visibility, no bleeding), has  a lower capacity for 
removal (ablation) of hyperplasia tissue compared to mono-
polar  transurethral resection. This is due to the fact that, 
firstly, roller vaporization may remove (evaporate) less tissue 
per time unit than in resection; and, secondly, the vaporiza-
tion of the tissue is much more durable and lasting, since 
the carbonized layer that is formed slows the process down 
and a  rehydration of tissue is required to resume the effect 
of vaporization. All of these require the application of roller 
vaporization in terms of a monotherapy for adenomas vol-
ume not exceeding 40 cm3 [69]. Vaporized resection, on the 
contrary, can be compared to standard transurethral resec-
tion in terms of efficiency and time of performance, but still 
it is as hard to be learned, because of the haemostatic effect 
of vaporizing loop,which  is not as pronounced as the “roller 
vaportrode “ whereas the technique performed on sections 
and the removal of adenomas requires considerable experi-
ence and training [31].
In order to overcome these deficiencies and reduce the 
number of complications mentioned above, as well as to 
improve the treatment outcomes of BPH and expand in-
dications for surgical treatment in patients with somatic 
symptoms, a new direction in endoscopy has been required. 
Bipolar surgery, which has developed new technologies – re-
section and plasmakinetic vaporization (Plasma Kinetic TM 
Gyrus), uses saline solutions as irrigation fluid ; no electric 
current flow is needed through the patient’s body due to the 
placement of 2 electrodes directly  into the instrument, com-
pared to standard monopolar resection, where the passive 
electrode is placed on the patient’s lower limb [70,71,72].
It is worth mentioning, there has been little research re-
ported on this issue, so far. The clinical effectiveness, indica-
tions and contraindications for this technique have not been 
fully described. There is a lack of knowledge regarding spe-
cific complications of this method. A high interest is paid to 
the comparative study of clinical characteriastics of postop-
erative period and distant treatment outcomes in patients af-
ter a standard monopolar transurethral resection with a loop 
electrode and plasmakinetic transurethral resection. These 
describe the actuality of the subject, both from a scientific 
and practical point of view, as well as the need for a compara-
tive study of the effectiveness of this endoscopic technique.
The number of patients with BPH is increasing continu-
ously, due to the growth of elderly population, development 
of diagnostic techniques, higher average life expectancy and 
men’s need to improve their quality of life. In the surgical 
treatment of BPH, transurethral resection shows a percent-
age range from 63.7 to 98.3% of all invasive treatment tech-
niques of prostatic hyperplasia. It took almost 50 years for 
TURP to replace open prostatectomy and become a prede-
termined intervention. However, complications like bleed-
ing, retrograde ejaculation and TUR syndrome limit the use 
of this method in a number of patients [68]. Currently, trans-
urethral resection of the prostate (TURP), which is consid-
ered the “gold standard” for treatment of urinary obstruc-
tion caused by benign prostatic hyperplasia, is entailing a 
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real threat. New minimally invasive endoscopic laser meth-
ods are being implemented in patients with IVO, caused by 
prostatic hyperplasia (BPH), specifically laser enucleation 
[10,62,73,74,75], which allows to reduce the number of com-
plications and patient’s hospital stay.
Laser technologies have been successfully applied in 
medicine worldwide for more than 35 years. In the last 25 
years, laser treatment has been used in the most specific 
medical specialties, and presents an ideal combination of 
cutting and coagulation properties.
For the first time, neodymium laser was applied to the 
coagulation of prostatic tissue in 1979 by R. Bowering et al. 
Since 1990-1994, there appeared  first international scien-
tific works [10,62,63, 76,77], including Russian scientists 
[54,59,61], regarding the successful use of laser radiation 
and, particularly, the neodymium laser with a wavelength of 
1064 nm in the treatment of patients suffering from BPH.
At present, both contact or non-contact laser methods 
are being used for coagulation and vaporization of hyperpla-
sia tissue of the prostate in order to decrease its volume and 
provide a proper flow of urine from the bladder [78].
Holmium YAG laser treatment of the prostate has devel-
oped from simple ablation, resection to the modern tech-
nique of enucleation. Holmium laser ablation of the pros-
tate (HoLAP) is a painstaking process because of slow tissue 
ablation rate and is indicated only for small glands. HoLRP 
involves a partial enucleation of each prostatic lobe, which is 
then divided into small pieces of the lobe, still attached to the 
capsule. Although HoLRP was faster than HoLAP, it still has 
a longer duration than TURP. The use of morcellator led to 
the onset of HoLEP technique – Holmium laser enucleation 
of the prostate [76].
Holmium YAG laser resection is usually applied in cases 
when the prostate volume does not exceed 60 cm3; enucle-
ation is performed in larger prostate. It is known that laser 
surgery of BPH has both advantages and disadvantages. The 
advantages of this method include lack of intraoperative 
and postoperative bleeding and “TUR syndrome”, reduced 
invasive and traumatic features, and a very important fact, 
the possibility to be performed in patients with high surgical 
and anesthesiological risks. The disadvantages of laser meth-
od are the prolonged postoperative urine discharge, longer 
duration of intervention, the relatively non-radical character 
of treatment, the late onset of dezobstruction, considerable 
postoperative dysuria. Recently, some authors [54,79] have 
been studying perspectives of mutual combination of these 
laser methodologies in surgical treatment of patients with 
BPH. The laser surgery of BPH, like other less invasive meth-
ods of surgical treatment of this disease, ensures a successful 
surgical outcome by reducing life-threatening complications 
[62,80]. However, despite the successful results, many issues 
of laser surgery of BPH, still remain uncertain.
Lower urinary tract obstruction caused  
by sclerosis of the bladder neck and prostate
Infravesical obstruction caused by bladder neck sclerosis 
is the result of the scarring process of the connective tissue 
subjected to inflammation in the region of bladder neck and 
which  partially affects the muscular wall; or a result of ex-
cessive electrocautery in that area during TURP procedure, 
as well as excessive suturing of the BPH lodge following a 
classic adenomectomy.
Bladder neck sclerosis according to N. Lopatkin and A. 
Pugaciov [81] affects 65% of patients, A. Liuliko and T. Kodiri 
[12] recorded 77.4% of cases, whereas G. Bakiev [82] stated 
80.9%.  In its turn secondary BNS is one of the complications 
of late postoperative period in patients with benign prostatic 
hyperplasia, which occurs in 0.4 to 24.8% of cases, thus sec-
ondary BNS remains a serious problem in modern urology. 
In the study conducted by Ying-Huei Lee et al. [83] on a lot 
of 1.135 patients who underwent standard transurethral re-
section (TURP), 9.7% of patients developed BNS during the 
mean postoperative follow-up of 37 months. Small prostates 
were initially diagnosed in most of these cases [83].Another 
study conducted by W. Al-Singary et al. [84] on a lot of 900 
patients during a follow-up of 4 years after mopolar TURP 
procedure, showed that 3.4% of patients developed BNS with 
a mean resected prostatic tissue weight of 11 ± 3.7 g. One of 
the causes of BNS development after the surgical treatment 
for BPH is the concomitant chronic prostatitis [15], whereas 
the onset of the sclerotic process starts in the postoperative 
period, following a trauma or acute inflammatory process 
in the bladder neck region [11]. Sclerotic processes most ac-
tively evolve in conditions of hypoxia, whilst inflammatory 
process will only worsen the situation [70,85].
The pathological condition may develop through the 
stricture or complete obliteration of the bladder neck and 
is characterized by IVO progression to full retention of 
the micturition, which further will require bladder drain-
age (cystostomy). In the latter case, the condition is associ-
ated with social inadequacy of the patient, development of 
chronic pyelonephritis, chronic cystitis and eventually blad-
der sclerosis.
The incidence of developing bladder sclerosis is different, 
according to the types of surgical interventions. Thus, there 
were recorded 1.7% to 3.9% of cases following transvesical 
adenomectomy, 2-10% of patients after TURP, 1.28% of pa-
tients treated with  bipolar plasmakinetic resection, 0.5% to 
3.8% of cases occurred after Holmium laser TURP. Accord-
ing to EAU Guidelines, the risk of developing this pathology 
is 4% in patients treated by TURP, 1.8% after an open sur-
gery for BPH and 0.5% to 14.6% after radical prostatectomy 
for prostate cancer [86,87,88].
Therefore, secondary bladder neck sclerosis is one of the 
most common chronic complications following a surgical 
treatment of the prostate.
According to N. Nashivocnikova, [29,89], the incidence 
of bladder neck sclerosis after a surgical treatment of BPH is 
15.5% and does not depend upon the surgical method, pros-
tate size and patient’s age, but it depends on the recurrence 
of  hemodynamic disorders in the pelvis and the presence of 
inflammation in the prostate.
The presence of microcirculatory disorders in the blad-
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der neck in patients with BPH is a pathogenetic factor in the 
development of basic sclerosis. It is detected in patients at 
already preoperative stage, lasts throughout the postopera-
tive period and as a result of a chronic inflammation may 
lead to pathological scarring [85]. The improvement of mi-
crocirculatory parameters in bladder neck region in patients 
with BPH, prior to surgery and during the immediate post-
operative periods, can prevent the developing of bladder 
neck sclerosis, whilst in patients with BNS help reduce the 
reccurrence rate from 7.9% to 0.82 % [70,85].
The severity of BNS and other chronic disorders of uro-
dynamics of the lower urinary tract is determined not only 
by changes in LUT, but also by the urodynamics of upper 
urinary tract (UUT). UUT changes are often decisive in as-
sessing the severity of the disease and the choice for surgical 
indications [90]. For this reason the study of disease severity 
in selecting indications for surgery is an important step in 
the treatment of bladder neck sclerosis [91].
According to bibliographical data, the diagnosis and 
treatment tactics of bladder neck sclerosis entail some diffi-
culties, since many tests that determine the type of disorder, 
also may refer to other causes of infravesical obstruction, as 
well. Diagnosis is particularly difficult in the early stages, 
when there is no clear image of the degree of clinical charac-
teristics and radiological data [4;50].
Detection of bladder neck sclerosis is based on patient’s 
complaints regarding difficulties in urination or inability 
to empty the bladder in a natural way; on the information 
about previous surgeries and complicated evolution of im-
mediate postoperative period. The disease is diagnosed via 
radiological examination and endoscopic methods.
Therefore, in BNS , the findings of ascending urethro-
grams may determine the free permeability of the urethra 
up till the bladder neck; whilst in the urethra stricture, it is 
detected in the distal region of the urethra (in relation to the 
bladder neck).  In case of “Prevesical space”, there is an extra 
cavity between the bladder neck stenosis and the constricted 
portion of the urethra, which is shown on the urethrogram. 
In order to determine the degree of manifestation and loca-
tion of IVO, the ascending urethrography of contrast is per-
formed; and if micturition is still present, then – uroflowm-
etry and ureteroscopy. The differential diagnosis of patients 
with other obstructive complications after previous surgeries 
is carried out in: urethral stricture, false urethral channels, 
“Prevesical space” and sclerosis of the prostate. Common 
symptoms for these conditions are difficulties in urination 
or its complete retention.
An important issue in contemporary urology is the treat-
ment of bladder neck sclerosis, since it is being widespread, 
especially in men of older and senile age [92]. Postoperative 
bladder neck sclerosis is a complication of TURP or radi-
cal prostatectomy, which still remains an unsolved problem 
[93,94]; although, a number of surgical treatment methods 
are known for both primary and secondary BNS.
The purpose of treatment of bladder neck sclerosis is to 
restore the permeability of vesicourethral segment through 
various methods of interventions. There were submitted 
various proposals to solve this problem. Therapeutic options 
range from regular dilation with balloon with about 50% of 
recurrencies, to cold loop resection, TURP of bladder neck 
in order to place the stent and others. The indication for in-
tervention is the sign of IVO.
The choice of the surgical type is largely determined by 
the degree of the bladder and kidneys disorder [86,90,95].
Until recently, the most of old aged and senile patients 
have undergone open resection for bladder neck sclerosis. 
This surgery, despite its effectiveness, was quite traumatic 
and led to development of complications [92].
Transurethral resection of scar tissue (TURP of blad-
der neck), originally described by Sachse in 1974 remains 
the standard method of treatment for bladder neck ob-
struction in men with postoperative bladder neck sclerosis 
[92], which compared to the open surgical intervention is 
described as being highly effective in treatment of infravesi-
cal obstruction and symptoms caused by it. It is considered 
less traumatic, gives chances for being repeated without any 
significantly increased risk for the patients and it obviously 
provides a shorter rehabilitation period etc. However, the 
proposed surgical treatment methods are complex, multi-
level and often ineffective. The existing treatment methods 
can cause hemorrhage, hematomas and scar formation with 
subsequent recurrent relapses and may require repeated in-
terventions. The above listed surgical interventions are con-
sidered inefficient since there is no assessment of the mani-
festation degree of the scarring process on the bladder wall, 
of the conditions of trigonal-urethral and vesicourethral re-
gions, in terms of infravesical obstruction treatment.
There are several poorly highlighted aspects. These con-
cerns include: a complex of necessary diagnostic methods, 
more accurately assessed indications and contraindications 
for transurethral and “open” resection for the bladder  neck 
in patients with BNS, technical peculiarities of endoscopic 
and open surgeries to patients of this category, the study of 
intraoperative and postoperative complications of transure-
thral and transvesical resection of the bladder neck and their 
preventive measures, peculiarities of pre– and postoperative 
management of elderly and senile patients.
Since, the surgical intervention is considered the basic 
method in the treatment of BPH and complications are in-
evitable, the number of postoperative patients with prostate 
and bladder neck sclerosis, obviously increases [92]. Thus, 
M. J. Bader et al. assessed the obstructive complications rate 
from 1.1% to 24.8% of cases, after an adenomectomy; whilst 
according to T. Bach et al. [93], bladder neck sclerosis is ob-
served in 3.6 to 17.9% of patients after radical prostatectomy 
or TURP.
Therefore, a further research and development of less 
traumatic alternative treatment options are required to be 
learned and implemented, as well as the improvement of al-
ready existing methods such as bipolar plasma vaporization 
[86,94], using various laser  treatments with good results, 
including neodymium, argon and holmium (YAG laser) 
[64,93,96].
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Prostate sclerosis is a disease, where the sclerosis paren-
chyma of the gland constricts the prostatic urethra, narrows 
the bladder neck and vesical sections of ureters, compresses 
the deferens channels, causes dysfunction during micturition 
and urinary stasis, causes a decrease in kidney function and 
disruption of various phases of the copulative cycle. Prostate 
sclerosis does not refer to the category of widely spread uro-
logical diseases. It raised the interest among urologists, since 
the infravesical obstruction caused by the prostate sclerosis 
is found in 52.8% of younger men (up to 59 years) and if left 
untreated ends up with the end-stage kidney failure. Com-
parative studies of the prostate sclerosis and BPH incidence 
have established a ratio of 1: 5 of these conditions in 1970-
80 and 1: 3.2, in 1986-1995, which shows an increasing ten-
dency of cases. Particularities of the prostate sclerosis pro-
cess have been established. In younger men (up to 50 years) 
prostate sclerosis is often associated with focal hyperplasia 
of parenchyma and develops on the background of chronic 
inflammation. In patients older than 50 years, modified atro-
phic parenchyma, with cystic changes are detected [97].
According to the unanimous opinion of scientists, the 
prostate sclerosis is genetically related to prostatitis [98]. The 
inflammatory process in the gland is found in 62% of cases. 
Chronic Prostatitis leads to BPH in 40-100% of cases [99].
Prostate sclerosis (73%) is one of the end- stages of the 
chronic inflammatory process in the prostate (chronic pros-
tatitis) [92,99]. This stage is characterized, as a rule, by a de-
crease in the inflammatory process activity; simultaneously, 
the organ is considerably replaced by a scar connective tissue 
[92]. Additionally, prostate sclerosis is a complication of the 
late period in patients who underwent adenomectomy (6%) 
or TURP (21%) related to BPH.  In some patients, prostate 
sclerosis causes infravesical obstruction. It was determined 
that in 23.9% of elderly men, infravesical obstruction is con-
ditioned by the development of prostate sclerosis and, that 
small BPH are most commonly associated with sclerotic 
changes in the prostate [92].
The treatment of prostate sclerosis is an important issue 
of the modern Urology regarding the widespread nature of 
this disease, especially in men of older and senile age [92]. 
Simultaneously, the increase in average life expectancy con-
siderably raises the number of patients of elderly and senile 
age, who also present intercurrent conditions, thus increas-
ing the risk for surgical interventions [40]. Intercurrent con-
ditions of other organs and systems complicate evolution 
and basic treatment in 35.8% of patients. Since high-risk 
surgical patients are reported in 13% to 17% of cases, they do 
not undergo a radical surgery; cystostomy is performed in-
stead, which leads to social inadequacy of the patient. Since 
the surgical intervention is considered the major method of 
treatment of BPH and the presence of obstructive complica-
tions is inevitable, the number of patients with prostate scle-
rosis increases, as well.  Obstructive complications after ade-
nomectomy are reported by V. Bazaev and A. Morozov [100] 
in 1.1% to 24.8% of cases. Thus, according to bibliographic 
sources, prostate sclerosis and benign prostatic hyperplasia 
are mostly prevalent among male urological in-patients, and 
therefore the effectiveness of treatment of these diseases is of 
great economic and social importance [2]. Currently, TURP 
is considered the most effective method of treatment of pros-
tate sclerosis in order to remove the infravesical obstruction, 
[101; 102].
Analysis of surgical outcomes based on a lot of 165 pros-
tate sclerosis patients and further improvement of urody-
namic parameters,  allowed L. Gorilovskii and M. Dobro-
hotov [92] to conclude that transurethral resection is an ef-
fective method to treat infravesical obstruction and restore 
the micturition , especially in patients of older age and se-
nile, while improving the quality of life, as well. Beneficial 
results, regarding the improvement of symptoms after the 
surgical treatment of prostate sclerosis, were determined 
in patients with obstructive symptoms of the disease rather 
than irritative ones. From the morphological point of view 
it has been proved that the prostate sclerosis is a result of 
the so-called stromal hyperplasia, being one of the types of 
prostate hyperplasia. [92]. It is based on the proliferation of 
stromal elements, although in some cases lax muscle fibre 
type stromae forms a nodule of  muscle fibre- type, so-called 
spheroids. The prostate in this case is rather consistent and 
slow-growing.
The main task in the surgical treatment of prostate scle-
rosis is to reduce the number of intraoperative complica-
tions, early and late postoperative complications and mor-
bidity rate. In order to achieve this goal, it is necessary to 
reduce the number of open surgeries and increase interest 
for endoscopic treatment methods, specifically TURP, laser, 
and plasmakinetics.
However, despite the good results and the efficiency of 
TURP, it still does not lack complications like bleeding dur-
ing and after surgery (arising in 0.9 to 10% of patients), as 
well as the body water intoxication syndrome – “TUR syn-
drome” (0.1 – 1% of patients), which sometimes lead to un-
favorable results.
The mortality rate, even if it is lower than for open sur-
gery, it still remains quite high, which is particularly impor-
tant in elderly and senile patients [2]. All these aspects fa-
cilitate the search for optimized treatment technologies [92].
Subvesical obstruction caused by stricture and  
obliteration of the urethra
Urethral stricture is one of the most complicated urologi-
cal diseases. The incidence of the stricture of the urogenital 
system diseases constitutes about 6% of cases [12]. It is actu-
ally thought, that the incidence of urethral strictures is much 
higher, since quite often patients, who complain of disorders 
in urination, are incorrectly diagnosed (i.e. atony of bladder, 
prostate adenoma, chronic prostatitis, chronic cystitis etc.). 
But the real disease, namely urethral stricture, is detected 
only during a further deep investigation, whereas in a num-
ber of cases, it remains undiagnosed [103].
Urethral stricture is the second most common cause of 
obstructive micturition disorders in men regarding the pros-
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tate diseases [104,105]. In the last two decades, the incidence 
of urethral strictures significantly increased. This is due to 
several factors: on the one hand, the increased number of 
severe damages of pelvic organs [106,107]; and on the oth-
er hand, as a result of the largely implemented endoscopic 
methods and transurethral resection [107]. The incidence of 
posterior urethral stricture and bladder neck sclerosis is par-
ticularly high [23,105,108].
Until the widespread practical implementation in urol-
ogy of endoscopic treatment methods, mostly, transurethral 
resection of the prostate in patients with urethral stricture, 
the major part was represented by patients who suffered a 
trauma. In this case, 47.7% of the patients were aged between 
21 to 40 years. Traumatic stricture was found in 84.7% of 
patients, including 9.6% of cases, caused by adenomectomy 
and medical manipulations [31]. Over 10 years, the last fig-
ure rose to 14.7% [109]. The iatrogenic cause of stricture oc-
currence is found in 24% of cases, whereas adenomectomy 
and TURP were the causes of stricture development in 13.6% 
and 10.5% of cases, respectively. A slightly different situation 
is noticed in case analysis of urethral obliteration. In 40.7% 
of cases, obliteration is caused by traumas; 39.53% of cases 
showed an iatrogenic cause (transvesical adenomectomy – 
33.72%, TUR of the prostate – 5.81%); obliteration arising 
after a previous plastic interventions in the urethra – 19.77% 
[89,110]. Patients with posterior urethral and bladder neck 
obliteration are the most difficult category of patients with 
urethral obstruction [82].
Urethral stricture is a condition characterized by various 
symptoms of lower urinary tract that are and depend on the 
cause, location and severity of the strictures [23]. The symp-
toms of urethral strictures (the urinary stream is character-
ized by a weak, thin, forceless, sometimes “dripping” flow) 
and possible complications (incomplete or complete reten-
tion of urine, fully distention of urinary tract and, even renal 
failure) may lead to confusion in the diagnosis of obstructive 
urinary diseases. Basic causes are commonly benign (infec-
tious, ischemic, iatrogenic, traumatic, congenital, undeter-
mined) or rarely, neoplastic (not examined in this study). 
The etiology of scar is characterized by traumatic, inflam-
matory and congenital causes. According to their location, 
they can be prostatic, membranous, bulbar, penile; accord-
ing to their size (expansion) short (≤ 2 cm), long (≥ 2 cm); 
with subtotal damage in 75-90% of the spongy urethra,  to-
tal spongy (total damage of spongy urethra) and total (total 
damage of the urethra); by number – single and multiple; 
according to the degree of narrowing of the urethra: mild 
– lumen is narrowed up to 50%; moderate – lumen is nar-
rowed to 75%; severe – lumen is  narrowed more than 75%; 
obliteration – no lumen.
Male urethral stricture is an obstructive polyetiologic 
disease, which involves urethral epithelium, spongy body, 
and in some cases paraurethral tissues. Due to the changes 
of scar tissue in the urethral walls, the progressive narrowing 
of the lumen diameter (in one or more places) occurs.
In elderly and senile men, a previous surgery is often the 
cause of urethral stricture or obliteration [82,105,106]. The 
list of interventions which lead to urethral strictures, most 
often includes the surgeries associated with benign prostatic 
hyperplasia: transvesical adenomectomy, transurethral re-
section of the prostate.
In recent years, it is complemented by radical prostatec-
tomy performed in prostate cancer. Urethral stricture fol-
lowing such type of surgery, obviously, occurs in patients 
of advanced or senile age [16,23]. There is a high risk for 
a considerable number of patients to undergo urologic sur-
gery, which is determined by a number of factors: increasing 
age of patients who undergo surgical treatment, along with 
elderly (61-74 years) and senile (75-90 years), often applied 
to long-lived patients (90 years and over); most patients with 
associated diseases are often subjected to surgical treatment 
i.e. lung diseases, chronic hypertensive disease, ischemic 
disease of the heart, anterior myocardial infarction with de-
velopment of cardiosclerosis, disease of  peripheral vessels, 
blood-vascular failure, consequences of impaired cerebral 
circulation, metabolic disorders such as diabetes, obesity, 
hormonal deficiency, drug intolerance [111].
Urethral trauma is ranked on the first place among the 
most male urogenital injuries [23,105,106]. One of the com-
plications of severe urethral trauma, which leads to pro-
longed loss in work capacity and often to disability, is its nar-
rowed scarring.
The increasing number of traumatic disorders of the ure-
thra leads to the steady growth of number of patients with 
stricture scarring, in most countries [112,113]. Meanwhile, 
there is an increasing number of recurrent strictures, which 
proves the low efficiency of surgical treatment methods [23, 
106,114,113,115]. Native authors [116,117,118] investigated 
the efficacy of treatment methods in open urethral strictures, 
especially the posttraumatic [116,118] and analyzed the out-
comes after an endourologic treatment of acquired urethral 
stricture, specifically iatrogenic and post inflammatory ure-
thral stricture, the peculiarities of urodynamic exam find-
ings in patients with primary and recurrent acquired ure-
thral strictures [118].
Even if urethral strictures have a relatively small share 
in urological pathology (3.7 to 6%), the issue of their treat-
ment refers to the most current situations in modern urol-
ogy [119]. This is due to the large number of complications 
and high recurrence rate (10-50%), which often lead to so-
cial inadequacy of this category of patients [120]. One of 
the current problems of urology is the treatment of urethral 
strictures of different genesis, including postoperative stric-
tures with different locations, following an adenomectomy 
[23,109].
The successful interventions in the urethra depend on 
the choice of optimal surgical method while taking into 
account the location, length and complication of stricture; 
the appropriate use of intervention techniques; the post-
operative treatment of patient; the overall condition of the 
body; the presence of recurrent diseases and complications 
[23,114,115,120].
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Patients with urethral strictures require a specialized and 
prolonged treatment. Surgery is a radical treatment method 
performed by means of open or endoscopic technique. The 
choice of a surgical method is based upon specific indica-
tions and contraindications, some of which are still consid-
ered controversial and largely discussed in related literature. 
As for example, the choice for optical uretrotomy in extend-
ed urethral strictures and its complete obliteration [23,34].
Until recently, the main methods of treatment of patients 
with urethral strictures were open and complex surgeries 
(i.e.urethroplasty, urethral reconstruction) as Holtsov-Mar-
ion, Solovov, Rusakov, Mikhailovsky etc. [23] most of which 
does not guarantee a full recovery. Unsatisfactory results of 
treatment in patients with urethral strictures are commonly 
met and reach up to 16-25% of cases. The open surgeries also 
include: different methods of anastomosis, urethral plastic 
surgery, displacement of grafts [23]. The efficiency rate of 
listed above treatment methods constitutes about 80-95% 
and are applied mainly in extended urethral strictures [25], 
and the overall rate of recurrence is about 5-20% [102,106]. 
Besides its traumatic and long rehabilitation period, the 
most common complications following open surgery are: 
postoperative suppuration, incidence of urinary fistulas, 
stricture recurrence, urethral obliteration, urinary inconti-
nence. The following side effects of surgery of the urethra 
should be reported: shortage of penis, erectile dysfunction 
and impotence associated with inevitable trauma of muscles, 
vessels and nerve endings of the perineum during the inter-
vention as well as urethral resection [82]. All this leads to 
social inadequacy or disability of this category of patients. 
Recently, great importance is paid to the development 
and implementation of modern technologies, especially 
minimally invasive methods of treatment of urological dis-
eases. Various endoscopic surgical methods are widely ap-
plied, which enable the efficient restoring of urethral per-
meability in the early follow-up period; endoscopic surgery 
is performed in urethral obliteration [89,121]. Currently, 
transurethral methods are widely used in treatment of this 
disorder, which are divided into cold knife urethrotomy, 
electroresection and laser urethrotomy. These include main-
ly internal visual urethrotomy; visual dilation of the stricture 
and insertion of the endoscope during transurethral inter-
vention of lower urinary tract; Otis urethrotomy, transure-
thral resection of the urethral sclerotic scar tissue [89,122].
Endoscopic treatment methods include internal optical 
urethrotomy; urethral endoscopic disobliteration; combined 
endoscopic interventions, which present the following ad-
vantages: minimum operational trauma; minimal duration 
of intervention; no significant intra– and postoperative 
complications. A number of authors have extensive experi-
ence of endoscopic treatment of urethral strictures, which 
allowed them to avoid complex open procedures, in some 
cases [89,122].
A palliative method to restore the micturition is internal 
visual urethrotomy – a minimally invasive endoscopic meth-
od of treatment, which actually consists of an incision per-
formed on the narrowed portion of the urethra and stroma 
lumen by means of special instruments [120,123]; thereby a 
normal urethral lumen is obtained. This surgical technique 
is performed via a visual management, where intraurethral 
longitudinal incisions are made on the stenotic segment us-
ing an optical urethrotome [88,124]. The success rate of this 
surgical procedure is 30 – 40% within a year, whilst failures 
are considered secondary effects of this apparently simple 
endoscopic technique. The main purpose of this method is 
the cure, viz. obtaining a steady functional urethral lumen 
without a need for further investigation, therefore cases of 
strictures less than 1 cm will be selected, with moderate 
spongiosal– fibrous process, located at level of bulbar ure-
thra.
Visual urethrotomy enables to perform a selective and 
precise incision, which prevents the emergence of many 
complications. The disadvantages of this method are: the 
prolonged follow-up period of patients, whereas its success 
depends on the intellectual level and readiness of the patient 
[125,103,126].
In order to improve a relatively modest success rate (up 
to 30-40%) on a long– term period, urethral stents (prosthe-
ses) can also be placed endoscopically at the level of stenotic 
urethral segment aiming to maintain the proper function of 
the urethral lumen. Except for its high price, this method 
does not decrease the recurrence rate of stenosis, and it is ex-
tremely difficult to treat a prosthetic and recurrent stricture.
During recent years, there have appeared a series of sci-
entific works regarding the benefits of this method (visual 
internal urethrotomy) [25,110,126,127] in the treatment of 
post-traumatic urethral strictures [128] and postinflamatory 
ones [119,128]; as about the treatment of postoperative ure-
thral strictures the results are more diverse and specific [129], 
according to reported data. Perhaps this is due to some char-
acteristics of stricture location following an adenomectomy, 
as a rule, placed in the proximal segment of the urethra and 
on the bladder neck region, or after a urethroplasty [130], 
as well as to the difficulties of surgical access,a fact which 
complicates considerably the choice for surgical technique. 
Finally, the main idea of all these communications was that 
visual internal urethrotomy is an effective method of treat-
ment of urethral stricture, which is characterized by less 
traumatic and better results. IVO is the surgical approach 
selected in less expanded urethral strictures; it may prevent 
the patient from undergoing repeated open plastic surgeries 
or reduce post urethroplasty recurrence [126,131]. If associ-
ated with appropriate anti-scar treatment during the post-
operative period, it may significantly reduce the number of 
recurrence and improve treatment outcomes [128,132,134].
In specialized literature, there is no unanimous opinion 
regarding the indications for IVO. M. Trapeznikova et al. 
[52,136] thinks that this method can be applied to all stric-
tures, regardless of their etiology, level of manifestation or 
impairment. The purpose of these procedures is the forma-
tion of the tunnel, as well as localization of a preserved por-
tion of the urethra. Some authors [134], made attempts to 
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use retrograde visual urethrotomy in treatment of urethral 
obliteration, but due to high trauma rate and probability of 
false paths onset (false urethra) ,this method has not been 
widely applied in practice. Surgical intervention is indicated 
only in cases of short urethral deficiency, the bladder neck 
is competent and there is a minimum displacement of the 
prostate and bulbar proximal urethra [119]. Although, the 
restoring of continuity is somewhat simple and potency is 
not affected by the procedure, still urethral dilatation, re-
peated visual urethrotomy and transurethral resection of 
stricture are very commonly used in 82% of patients. Most 
repeated urethrotomies are made in the first– year of follow-
up. It should be noted that in case if initial urethrotomy fails, 
alternative methods of treatment are applied, since repeated 
urethrotomy leads to only temporary improvement. Besides 
a false urethral path, a rectal perforation may often occur.
According to bibliographic data, recurrences follow-
ing IVO occur in about 80% of cases; after Frank M. [41], 
V. Bazaev, S. Urenkov [82] – in 15-50%, and according to 
A.M.  Naude [124] Giannakopoulos, et al. [135] – in 50% of 
patients. A number of authors [126; 136] reported about the 
high incidence of remote recurrence in treatment of patients 
with urethral stricture of inflammatory etiology by means of 
endoscopic urethrotomy.
Some authors [119] convincingly demonstrate that visual 
internal urethrotomy is an operation of urethral stricture se-
lection and the treatment of each patient must be initiated 
with visual urethrotomy. VIU is now a simple, accessible and 
technically easy to perform procedure. But this intervention 
can not be considered pathogenically argumented. Urethrot-
omy is a palliative surgery [122]. Any induced and unstiched 
wound, heals by scarring by secundam and formation of 
scars, therefore stricture recurrence is inevitable.
Therefore it is not surprising that the supporters of visual 
internal urethrotomy recommend the mandatory long-time 
survey, sometimes for life, while admitting however multiple 
repeated urethrotomies. According to several authors [122], 
the strictures recurrence in visual internal urethrotomy 
ranges from 30.8 to 58.2%. D. Pushkari et al. [120,137] re-
ported stricture recurrence after internal visual urethrotomy 
in 20-80% of patients.
Additionally, cold knife urethrotomy and diathermo-
coagulation are used in stricture incision along with laser 
irradiation has been positively assessed by several authors 
[72,138]. In opinion of I. Karpuhin et al. [119]; A. Martov 
et al. 103; 110] V. Voinescu et al. [139]; C. Moldoveanu [86]; 
M. Lucan et al. [140], urethral strictures laser therapy is an 
alternative approach to classical cold knife urethrotomy.  The 
best results are obtained in non-recurrent strictures of less 
than 1 cm long. In cases of recurrent strictures longer than 
1 cm long, the alternative to open surgery should be consid-
ered. In severe cases with multiple recurrences, the method 
does not provide satisfactory results, whereas urethroplasty 
is considered the best indication for these patients [139,141].
Thus, according to some authors [58,103,142], the  use 
of  the holmium laser in the treatment of extended urethral 
strictures showed good results in 80.9% of cases, whilst the 
recurrence rate of the disease being of 5.5%;  while in the 
treatment of complete urethral obliteration following  re-
peated surgical interventions, this method of treatment may 
be the only alternative procedure. The advantages of laser 
surgery, compared to other methods of correction of ure-
thral strictures, are:  the formation of soft, small sized scars 
(mild impaired elasticity), and a reduced activity of fibro-
blasts during epithelialization. Moreover, bloodless dissec-
tion of the laser has the advantage to limit the use of the ure-
thral catheter in the postoperative period.
Surgical treatment methods of urethral strictures do 
solve out satisfactorily all the problems related to this dis-
ease. Thus, the open surgical treatment outcomes still re-
main low: recurrence of urethral strictures are found in 5 
to 37.4% of cases, impotence development in 34.9 to 80.0% , 
shortening of the penis in 24% of patients, operative wound 
suppuration from 10.4 to 16,8% of the cases [53,102,122].
Endourological methods of treatment in urethral stric-
tures, in many cases, replaced complex open surgeries, thus 
significantly reducing the rate of postoperative complication 
[105]. However, the recurrence rate of urethral strictures af-
ter a primary endoscopic recovery of urethra (visual internal 
urethrotomy) is 8-23% [119,128]. Endoscopic reconstruc-
tion efficiency remains low at 30-50% [23], which leads to 
incapacity to work, disability and social inadequacy of the 
patient.
Despite the reported diversity of minimally invasive pro-
cedures, the results still remain unsatisfactory in treatment 
of long strictures and somewhat doubtful for medium length 
of stricture. Thus, for example, the use of electroresection 
may generate a deeper scar process, due to a serious electri-
cal injury of the peristrictural tissue, which does not guaran-
tee getting good results [141,143]. There is also an opinion 
that urethroplasty is indicated in the treatment of long stric-
tures, complicated by false channels, or in complete urethral 
obliteration [141,144].
Low efficiency of endoscopic correction is, in fact, related 
to inadequate radicalism of resection of the sclerotic urethral 
tissue, inadequate management of pre– and postoperative 
period, the presence of microcirculatory and trophic disor-
ders in the region of the urethral stricture [25].
Therefore, besides the surgical procedures, the pathoge-
netic therapy must be applied in the treatment of urethral 
strictures, in order to eliminate edema, inflammation and 
improve the trophic of the urethral tissue [53,131].
Hitherto, native and foreign researchers have proposed 
a series of conservative and surgical methods of treatment 
of urethral strictures in men [109,116,133,145]. However, 
the indicators of treatment efficiency remain at a fairly low 
level. Thus, postoperative stricture recurrence is  reported in 
30-75% of cases, which requires repeated surgical interven-
tions and has an extremely negative impact on quality of life. 
Additionally, the irrational use of surgical possibilities leads 
to an increased number of patients with extended urethral 
strictures, who may need reconstructive surgery [88].
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Therefore, treatment of urethral strictures is one of the 
most acute and contradictory issues in modern urologic sur-
gery.  Specialized literature describes the comparative char-
acteristics of different methods of treatment related to this 
disorder. It is important to note that outcomes in the treat-
ment of urethral strictures, performed by means of the same 
method, vary from author to author. Yet, there is no unique 
opinion regarding the optimal choice in surgical treatment 
of scarred urethral stricture. 
Data related to the recurrence and complication rate, 
surgical methods efficiency, as well as the role of  incision 
and laser coagulation of strictures are quite contradictory 
[28,119,144]. Also, there have not been set strict guidelines 
for the use of laser, depending on the size and location of the 
scarred stricture; there have not been studied the results of 
late treatment of strictures; and, most importantly, the recur-
rence rate after procedures performed by means of surgical 
laser [123,139]. Despite many studies and published scien-
tific researches, which contributed to the improvement of 
methods of diagnosis and treatment of urethral strictures in 
men, there are a number of issues which still require being 
revised [146].
Thus, there is no single solution of this problem regard-
ing the treatment of urethral stricture and obliteration. After 
hundreds of years, there  are still three directions in solving it 
viz. endoscopic correction, surgical treatment and electrode 
dilation of the urethra both as independent method or addi-
tional to the previous ones.  It is currently problematic to cre-
ate a single perfect method in treatment of both stricture and 
obliteration of the urethra. Accurate indications for a certain 
method,in order to restore the urethral permeability, depend-
ing on location and length, as well as to improve methods of 
treatment, would reduce the invasive risks without decreas-
ing the efficiency and may lead to success in each case.
A special place in clinical practice is reported to treat-
ment of postoperative urethral strictures and obliteration 
of elderly and senile patients [92]. Based on the statistical 
analysis in recent years, we can conclude indirectly about 
the number of patients of a certain age. We can mention 
that about 50% of patients with urethral stricture are over 
60. Moreover, due to different associated diseases, prolonged 
urinary infections after previous interventions involving the 
urinary tract, this category of patients shows less positive 
outcomes to any reconstructive intervention. In addition to 
that, this group of people presents higher complication and 
postoperative mortality rates. However, there are few reha-
bilitation activities in people of advanced and senile age, de-
pending on the method applied and postoperative urethral 
stricture treatment.
Hence, the development of endoscopic surgery has pro-
vided new, minimally invasive methods in treatment of 
infravesical obstruction of different genesis. The choice of 
method in treatment of infravesical obstruction is deter-
mined mainly by two mutually exclusive circumstances: the 
risk of surgical intervention and restoration of micturition. 
Often, the selected method must be less offensive compared 
to the results.
Laser surgery, plasmakinetic, transurethral resection and 
their combination present a number of advantages compared 
to open conservative interventions viz. fewer complications, 
the possibility to apply these methods to patients with severe 
associated diseases, short-term hospital stay, economic effi-
ciency.
However, despite the listed above advantages, endoscopic 
interventions, like any other surgeries are associated with 
complications in 15-30% of cases [63,149,150].
Native and and international scientific sources describe 
actually the method and technique of endoscopic treatment 
for infravesical obstruction, while there are fewer studies re-
garding its complications. One of the perspective directions 
that contribute to improvement of the treatment quality for 
infravesical obstruction is the combination of these methods 
(TURP and Ho Laser; TURP and Vaporization). According 
to their opinion, in this case, the benefits of one method will 
compensate the disadvantages for another. Nevertheless, 
the associated application of minimally invasive procedures 
does not prevent the incidence of various complications, 
which are less studied nowadays [119,129,147,148].
The most works of recent years, little or insufficiently de-
scribe different types of complications after endoscopic in-
terventions, as well as their criteria of prognosis.
Hitherto, the problem of surgical treatment of infravesi-
cal obstruction in endourology has not been highlighted or 
synthesized by any helpful studies from the Republic of Mol-
dova.
Conclusions
The literature analysis showed that prostate adenoma, 
sclerosis of bladder neck and prostate, urethral stricture and 
obliteration can be associated to the disorders that show 
signs of IVO, characterized by impairment of bladder emp-
tying, difficulties in micturition, retention of the urine and 
other types of dysuria.
IVO of urinary tract is a polyetiologic and pathological 
process, characterized by symptoms of lower urinary tract, 
which despite profound and multilateral study, still remains 
a serious problem of modern urology.  It is a major health 
and social problem due to its high occurrence in working 
aged patients, as well as limited preventive measures and 
progression to severe and fatal complications if no proper 
treatment is applied.
Recurrence of IVO is the most severe and late postopera-
tive complication due to the scarring process in the urethra 
and vesico-urethral segment (strictures and obliterations) 
and the continuous growth of adenomatous tissue mass (real 
or false BPH recurrence).
The latest results in this field, as well as the scientific and 
technical progress have changed considerably the traditional 
methods used in the treatment of many urological diseases 
causing infravesical obstruction. Modern urology provides 
plenty of treatment methods for these diseases, particularly, 
new endoscopic approaches (transurethral and plasmakinet-
ic vaporization, laser Holmium enucleation) and a variety of 
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their combinations, which display both advantages and dis-
advantages and compete with traditional ones, considered 
as basic methods over the past few decades; thus, creating 
opportunities for an individual approach to ensure a final 
success of a medical intervention.
A deeper and more complex comparative study is re-
quired in terms of application and effectiveness of the tech-
niques and endoscopic transurethral approaches used in 
the treatment of disorders manifested by IVO, such as BPH, 
BNS and PS, US and UO, aiming to broaden the range of in-
dications for the implementation of new minimally invasive 
transurethral methods into practice.
Optimization of problems, related to endoscopic treat-
ment of infravesical obstructive disorders, will help reduce 
unwanted symptoms of lower urinary tract, fight off com-
plications, including prevention of IVO recurrencies, fa-
cilitate recovery and improve patient’s quality of life after 
treatment.
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